Short answer: It mainly comes down to two compounding factors working against each other. First, a vegan diet contains no direct dietary source of EPA or DHA at all, since these particular fatty acids are found almost exclusively in fish, shellfish, and algae; vegans depend entirely on converting ALA from plant foods into these forms internally, and that conversion process is inherently limited. Second, many vegan diets also tend to be relatively high in omega-6 fatty acids from vegetable oils, and omega-6 competes with ALA for the same conversion enzymes, further reducing how much actually gets converted. Together, these two factors explain why blood levels of EPA and DHA tend to run lower in vegans than in people who eat fish regularly.
No Direct Dietary Source Means Full Reliance on Conversion
This is the more fundamental of the two factors. EPA and DHA are concentrated almost exclusively in marine sources, meaning a vegan diet simply doesn’t contain them directly, full stop. Vegans instead depend entirely on the body’s own ability to convert ALA, found in foods like flaxseed, chia, and walnuts, into these longer-chain forms. As covered in the broader research on this conversion pathway, that process is consistently inefficient for most people, generally converting under 8 percent of ALA into EPA and under 4 percent into DHA. For someone eating fish regularly, this conversion inefficiency barely matters, since they’re getting EPA and DHA directly from food. For a vegan, though, it’s the only route available, which means any inefficiency in that pathway translates directly into lower resulting levels.
Higher Omega-6 Intake Compounds the Problem
Here’s a genuinely important compounding factor that often gets overlooked: many vegan diets, particularly those relying heavily on vegetable oils, also tend to run higher in omega-6 fatty acids than the average omnivorous diet, and that matters quite a bit for this specific issue. A frequently cited older study on this exact question found that the dietary omega-6 to omega-3 ratio was 16 for vegans compared to 6 for meat-eaters in the population studied, a substantially wider gap. This matters mechanistically because the same enzymes responsible for converting ALA into EPA and DHA are also used to process omega-6 fatty acids, and the two compete for that shared enzymatic capacity. A higher relative intake of omega-6 effectively crowds out some of the limited conversion capacity that would otherwise be available for ALA, making an already inefficient process even less productive.
What the Research on Blood Levels Actually Shows
This combination of factors shows up consistently when researchers actually measure blood levels rather than just dietary intake. A 2025 study measuring the Omega-3 Index across different diet groups found that vegans had the lowest Omega-3 Index among all groups studied, notably lower than pescatarians and non-vegetarians who consumed fish or other marine-derived omega-3 sources. This finding lines up with a broader body of similar research on the topic, which has repeatedly found the same general pattern across different study populations.
Not Every Study Finds the Same Size Gap
One frequently cited finding from the large European Prospective Investigation into Cancer and Nutrition study found that vegan women in that particular cohort actually showed more long-chain omega-3 fatty acids in their blood than fish-eaters, meat-eaters, and lacto-ovo-vegetarians did, despite having no direct dietary intake of EPA or DHA. It’s a genuinely interesting outlier, and a useful reminder that individual variation can affect where any particular vegan population lands. It doesn’t overturn the broader pattern seen across most studies, but it’s worth knowing about.
What This Means Practically
Taken together, the general pattern holds up well across most of the available research: a diet with no direct EPA or DHA source, combined with a conversion pathway that’s already limited and further strained by typically higher omega-6 intake, tends to produce lower blood levels of these fatty acids in vegans compared to people who eat fish. This is precisely the situation that algal DHA and EPA supplementation was developed to address, since it delivers these fatty acids directly, bypassing the ALA conversion bottleneck and the omega-6 competition issue entirely.
- Vegan diets lack a direct dietary source of EPA and DHA. This puts full reliance on an inherently inefficient internal conversion process from ALA.
- Higher omega-6 intake, common in many plant-based diets, further reduces conversion efficiency. The shared enzyme pathway means more omega-6 in the diet can mean less capacity left over for converting ALA.
- Individual results vary, and not every study finds the same size gap. This is a well-documented general pattern, not an absolute universal rule for every vegan or every study population.
So while it would be an overstatement to say every vegan definitely has low omega-3 levels, the underlying mechanisms explaining why this pattern shows up so consistently in the research are genuinely well understood, and they point pretty clearly toward the value of a direct EPA and DHA source for anyone whose diet doesn’t otherwise include one.
